根据您的工艺进行浏览
- Home
- 根据您的工艺进行浏览
- 血液制品
血液制品
血液制品病毒过滤的先驱
自1989年以来，Planova™ 病毒过滤器在确保血液制品（如免疫球蛋白、凝血因子、α-1-抗胰蛋白酶、c1抑制剂等）的病毒安全性方面已获得多家制药公司的信赖。浏览本页面，查找可能有助于提高血浆衍生产生产工艺安全性和效率的资源。
专题文献
Removal of small viruses (parvovirus) from IgG solution by virus removal filter Planova™ 20N
Hongo, T., et al.
Asahi Kasei Medical Co., Ltd. and Yamaguchi University
Journal of Membrane Science 278: 3-9
2006
Implementation of a 20-nm pore-size filter in the plasma-derived Factor VIII manufacturing process
Furuya, K., et al.
Japanese Red Cross Plasma Fractionation Center
Vox Sanguinis 91: 119-125
2006
Viral safety of C1-inhibitor NF
Terpstra, F. G., et al.
Sanquin Research and Landsteiner Laboratory of the Academic Medical Center of the University of Amsterdam and Sanquin Plasma Products
Biologicals 35: 173-181
2007
专题演示文件
您需要登录才能下载文件
The Application of Planova™ BioEX in the Plasma-Derived IVIG Manufacturing Process
Yang HuHu, Engineer, Shandong Taibang Biological Products, Co., Ltd.
16th Planova™ Workshop
Nov 7, 2013 to Nov 8, 2013 Rome
Effective and Robust Virus Filtration
Nathan J. Roth, Senior Director & Head Global Pathogen Safety, CSL Behring
19th Planova™ Workshop
Sep 22, 2016 to Sep 23, 2016 Philadelphia
Understanding Planova™ Virus Filtration and Designing Robust Virus Filtration Processes
Tomoko Hongo-Hirasaki, Senior Scientist, Group Manager of Evaluation and Analysis, Asahi Kasei Medical
20th Planova™ Workshop
Nov 9, 2017 to Nov 10, 2017 Prague
